1. Home
  2. Labeler Index
  3. Synergy Health Ast, Llc
  4. 71161-154
  5. NDC Package Code: 71161-154-01 Cabotegravir And Rilpivirine

NDC Package 71161-154-01 Cabotegravir And Rilpivirine

Powder - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
71161-154-01
Package Description:
2250000 mg in 1 BAG
Product Code:
71161-154
Non-Proprietary Name:
Cabotegravir And Rilpivirine
Substance Name:
Rilpivirine
11-Digit NDC Billing Format:
71161015401
Product Type:
Drug For Further Processing
Labeler Name:
Synergy Health Ast, Llc
Dosage Form:
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s):
RILPIVIRINE 300 mg/300mg
Sample Package:
N/A
Marketing Category:
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date:
03-13-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 71161-154-01?

The NDC Packaged Code 71161-154-01 is assigned to an UNFINISHED drug package of 2250000 mg in 1 bag of Cabotegravir And Rilpivirine, drug for further processing labeled by Synergy Health Ast, Llc. The product's dosage form is powder and is administered via form.

Is NDC 71161-154 included in the NDC Directory?

Yes, Cabotegravir And Rilpivirine is an UNFINISHED PRODUCT with code 71161-154 that is active and included in the NDC Directory. The product was first marketed by Synergy Health Ast, Llc on March 13, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 71161-154-01?

The 11-digit format is 71161015401. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-271161-154-015-4-271161-0154-01